Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Article without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) days of discontinuation, Collaborator agrees that ICD may continue developing the Test Article. In that event, the following will apply:
Appears in 17 contracts
Samples: Public Health Service, And Development Agreement, Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR)
Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Article without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) days of discontinuation, Collaborator agrees that ICD IC may continue developing the Test Article. In that event, the following will apply:
Appears in 8 contracts
Samples: Cooperative Research and Development Agreement (Curative Biotechnology Inc), Research and Development Agreement (Ziopharm Oncology Inc), Cooperative Research and Development Agreement (Edge Therapeutics, Inc.)
Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Article without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) […***…] days of discontinuation, Collaborator agrees that ICD may continue developing the Test Article. In that event, the following will apply:
Appears in 4 contracts
Samples: Agreement (Tracon Pharmaceuticals, Inc.), Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Research and Development Agreement (Tracon Pharmaceuticals Inc)
Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Test-Article Investigational Agent without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) days of discontinuation, Collaborator agrees that ICD may continue developing the Test ArticleArticle Investigational Agent. In that event, the following will apply:
Appears in 3 contracts
Samples: Material Transfer Agreement (Newlink Genetics Corp), Research and Development Agreement (Newlink Genetics Corp), Research and Development Agreement (Newlink Genetics Corp)
Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Article without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) […***…] days of discontinuation, Collaborator agrees that ICD may continue developing the Test ArticleArticle only to the extent necessary to complete the work outlined in the Appendix A, Research Plan. In that event, the following will apply:: ***Confidential Treatment Requested PHS ICT-CRADA Case Ref. No.02661 MODEL ADOPTED June 18, 2009 TRACON CONFIDENTIAL
Appears in 2 contracts
Samples: Research and Development Agreement (Tracon Pharmaceuticals, Inc.), Research and Development Agreement (Tracon Pharmaceuticals Inc)
Collaborator Failure to Continue Development. If Collaborator suspends development of the Test Article Investigational Agent without the transfer of its active development efforts, assets, and obligations to a third party within ninety (90) days of discontinuation, Collaborator agrees that ICD may continue developing the Test ArticleArticle Investigational Agent. In that event, the following will apply:
Appears in 2 contracts
Samples: Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR), Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR)
